Glycogen synthase kinase-3 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glycogen synthase kinase-3 inhibitor, covering 2026-03-12 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy [Phase 2]